Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Juergens, A; Pels, H; Rogowski, S; Fliessbach, K; Glasmacher, A; Engert, A; Reiser, M; Diehl, V; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Kroschinsky, F; Bode, U; Herrlinger, U; Linnebank, M; Deckert, M; Fimmers, R; Schmidt-Wolf, I G H; Schlegel, U (2010). Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Annals of Neurology, 67(2):182-189.

Pels, H; Juergens, A; Glasmacher, A; Schulz, H; Engert, A; Linnebank, M; Schackert, G; Reichmann, H; Kroschinsky, F; Vogt-Schaden, M; Egerer, G; Bode, U; Schaller, C; Lamprecht, M; Hau, P; Deckert, M; Fimmers, R; Bangard, C; Schmidt-Wolf, G; Schlegel, U (2009). Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. Journal of Neuro-Oncology, 91(3):299-305.

Rutkowski, S; Gerber, N U; von Hoff, K; Gnekow, A; Bode, U; Graf, N; et al (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncology, 11(2):201-210.

Möricke, A; Reiter, A; Zimmermann, M; Gadner, H; Stanulla, M; Dördelmann, N; Löning, L; Beier, R; Ludwig, W D; Ratei, R; Harbott, J; Boos, H; Mann, G; Niggli, F; Feldges, A; Henze, G; Welte, K; Beck, J D; Klingebiel, T; Niemeyer, C; Zintl, F; Bode, U; Urban, C; Wehinger, H; Niethammer, D; Riehm, H; Schrappe, M (2008). Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111(9):4477-4489.

This list was generated on Wed Apr 24 10:32:22 2019 CEST.